首页> 外文期刊>Brain research >Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers.
【24h】

Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers.

机译:抗精神病药和抗抑郁药对健康志愿者行为监测的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Humans need to monitor their actions continuously to detect errors as fast as possible and to adjust their performance to prevent future errors. This process of action monitoring can be investigated by measuring the error-related negativity (ERN), an ERP component elicited immediately after an error. In the current study, we investigated action monitoring after administration of the classic antipsychotic haloperidol (2.5 mg), the atypical antipsychotic olanzapine (10 mg), and the antidepressant paroxetine (20 mg), a selective serotonin reuptake inhibitor. Healthy volunteers (N = 14) were administered the three compounds and placebo in a randomized, double-blind, single-dose, four-way cross-over design. All participants performed a speeded two-choice reaction task, while event-related potentials and behavioral measurements were obtained. Both haloperidol and olanzapine significantly reduced ERN amplitudes. After paroxetine, the ERN was not different from placebo. N2 congruency effects were not affected by treatment condition. Only olanzapine demonstrated behavioral effects, namely a slowing of responses, an increase in error rates, and the absence of performance adjustments. The attenuated ERNs after the dopamine antagonist haloperidol are in line with the presumed role of dopamine in action monitoring. Haloperidol is thought to block dopaminergic signaling, thus reducing ERN amplitudes. On the other hand, the effects of olanzapine are mainly caused by its sedative side effects, leading to a decline in motivation and appraisal of errors. Finally, the absence of any effects after paroxetine suggests that serotonin transmission does not play a direct role in regulating mechanisms related to action monitoring.
机译:人类需要持续监控自己的行为,以尽快发现错误并调整其性能以防止将来发生错误。可以通过测量错误相关的负性(ERN)(错误后立即引起的ERP组件)来研究此动作监视过程。在本研究中,我们研究了经典抗精神病药物氟哌啶醇(2.5 mg),非典型抗精神病药物奥氮平(10 mg)和抗抑郁药帕罗西汀(20 mg)(选择性5-羟色胺再摄取抑制剂)的给药后的动作监测。健康志愿者(N = 14)以随机,双盲,单剂量,四向交叉设计方式给予三种化合物和安慰剂。所有参与者都执行了快速的两选反应任务,同时获得了与事件相关的电位和行为测量。氟哌啶醇和奥氮平均能显着降低ERN振幅。帕罗西汀治疗后,ERN与安慰剂没有区别。 N2一致性效应不受治疗条件的影响。只有奥氮平表现出行为影响,即反应减慢,错误率增加和缺乏性能调整。多巴胺拮抗剂氟哌啶醇后的减弱的ERNs与多巴胺在动作监测中的假定作用一致。氟哌啶醇被认为可阻断多巴胺能信号传导,从而降低ERN振幅。另一方面,奥氮平的镇静作用主要由其镇静作用引起,导致动机下降和对错误的评估。最后,帕罗西汀治疗后没有任何作用表明5-羟色胺的传播在调节与动作监测有关的机制中没有直接作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号